Paloma Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-233,100
Closed -$5.33M 1145
2022
Q1
$5.33M Sell
233,100
-46,700
-17% -$1.14M 0.16% 84
2021
Q4
$7.72M Buy
+279,800
New +$7.49M 0.11% 134
2020
Q2
Sell
-16,300
Closed -$252K 2069
2020
Q1
$252K Sell
16,300
-44,600
-73% -$1.08M 0.01% 779
2019
Q4
$1.82M Buy
60,900
+17,200
+39% +$447K 0.03% 635
2019
Q3
$955K Buy
43,700
+20,700
+90% +$474K 0.02% 766
2019
Q2
$580K Sell
23,000
-11,100
-33% -$264K 0.01% 964
2019
Q1
$842K Buy
34,100
+4,600
+16% +$110K 0.02% 812
2018
Q4
$545K Buy
+29,500
New +$702K 0.02% 643
2018
Q2
Sell
-44,700
Closed -$712K 1638
2018
Q1
$712K Buy
+44,700
New +$832K 0.01% 1171
2017
Q1
Sell
-25,000
Closed -$363K 1962
2016
Q4
$363K Sell
25,000
-61,400
-71% -$1.13M ﹤0.01% 1643
2016
Q3
$2.12M Hold
86,400
0.03% 511
2016
Q2
$1.74M Buy
86,400
+43,400
+101% +$1.23M 0.02% 816
2016
Q1
$1.13M Buy
43,000
+18,000
+72% +$1.33M 0.02% 802
2015
Q4
$2.54M Buy
25,000
+21,000
+525% +$2.36M 0.07% 281
2015
Q3
$714K Buy
+4,000
New +$933K 0.02% 833

Other funds holding BHC

Paloma Partners's BHC Position: Q2 2022 in Review

Paloma Partners sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.

Paloma Partners first reported a position in BHC in Q2 2013 and held it in 23 quarters. The position peaked at $7.77M in Q2 2013. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Paloma Partners reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 100 Bausch Health shares in Q2 2022, an estimated $2K.
  • Paloma Partners first reported a position in Bausch Health in Q2 2013 and held it in 23 quarters.
  • Paloma Partners's Bausch Health position peaked at $7.77M in Q2 2013.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.